Skip to main content

CVS Health Corporation (CVS) Stock

CVS Health Corporation Stock Details, Movements and Public Alerts

Stock Details

CVS Health Corporation (CVS), a prominent company in the healthcare sector within the healthcare plans industry, is based in USA and primarily trades on the NYSE.Currently, the stock is trading at $76.70. Over the past 52 weeks, it has ranged between $41.77 and $85.15. This places the current price at 90.1% of its 52-week high and 83.6% above its 52-week low. Recent trading volume was recorded at 134,287. The 14-day Relative Strength Index (RSI) stands at 49.61, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $65.20 by 17.64%. Similarly, it is above its 200-day moving average of $58.59 by 30.91%. The MACD histogram is 0.29, indicating bullish momentum (MACD Line: -0.56, Signal Line: -0.85). The International Securities Identification Number (ISIN) for this stock is US1266501006.

52-Week Range

$85.15 - $41.77

-9.92% from high · +83.62% from low

Avg Daily Volume

134,287

Latest volume

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

21.11

Near market average

Forward P/E

10.48

Earnings expected to grow

PEG Ratio

0.63

Potentially undervalued

Price to Book

1.24

EV/EBITDA

11.61

EPS (TTM)

$3.58

Price to Sales

0.25

Beta

0.62

Less volatile than market

How is CVS valued relative to its earnings and growth?
CVS Health Corporation trades at a P/E ratio of 21.11, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 10.48 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 0.63 suggests the stock may be undervalued relative to its growth rate.
What is CVS's risk profile compared to the market?
With a beta of 0.62, CVS Health Corporation is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 1.24 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

1.18%

Operating Margin

2.80%

EBITDA

$13.97B

Return on Equity

5.88%

Return on Assets

2.29%

Revenue Growth (YoY)

8.40%

Earnings Growth (YoY)

-43.20%

How profitable and efficient is CVS's business model?
CVS Health Corporation achieves a profit margin of 1.18%, meaning it retains $1.18 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 2.80% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 5.88% and ROA at 2.29%, the company achieves moderate returns on invested capital.
What are CVS's recent growth trends?
CVS Health Corporation's revenue grew by 8.40% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 43.20% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against HEALTHCARE PLANS industry averages for proper context.

Dividend Information

Dividend Per Share

$2.66

Dividend Yield

3.51%

Ex-Dividend Date

Oct 23, 2025

Dividend Date

Nov 3, 2025

What dividend income can investors expect from CVS?
CVS Health Corporation offers a dividend yield of 3.51%, paying $2.66 per share annually. This above-average yield of 2-4% provides meaningful income while still allowing the company to reinvest for growth. It compares favorably to the S&P 500 average and offers competitive returns versus bonds in the current rate environment. To receive the next dividend, shares must be purchased before the ex-dividend date of Oct 23, 2025.
How reliable is CVS's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - CVS Health Corporation pays $2.66 per share in dividends against earnings of $3.58 per share, resulting in a payout ratio of 74.30%. This high payout ratio of 60-90% leaves limited earnings for reinvestment. While currently sustainable, there's less buffer for dividend growth or protection during earnings downturns. The next dividend payment is scheduled for Nov 3, 2025.

Company Size & Market

Market Cap

$96.1B

Revenue (TTM)

$384.33B

Revenue/Share (TTM)

$304.54

Shares Outstanding

1.27B

Book Value/Share

$61.07

Asset Type

Common Stock

What is CVS's market capitalization and position?
CVS Health Corporation has a market capitalization of $96.1B, classifying it as a large-cap stock ($10B-$200B). Large-caps are typically industry leaders with established business models, offering a balance of stability and growth potential. They often provide dividend income and are core holdings in institutional portfolios. With 1.27B shares outstanding, the company's ownership is widely distributed. As a participant in the HEALTHCARE PLANS industry, it competes with other firms in this sector.
How does CVS's price compare to its book value?
CVS Health Corporation's book value per share is $61.07, while the current stock price is $76.70, resulting in a price-to-book (P/B) ratio of 1.26. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$82.50

7.56% upside potential

Analyst Recommendations

Strong Buy

7

Buy

14

Hold

5

Sell

0

Strong Sell

0

How reliable are analyst predictions for CVS?
26 analysts cover CVS with 81% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $82.50 implies 7.6% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on CVS?
Current analyst recommendations:7 Strong Buy, 14 Buy, 5 Hold, 00The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 1, 2025, 06:07 AM

Technical Indicators

RSI (14-day)

49.61

Neutral

50-Day Moving Average

$65.20

17.64% above MA-50

200-Day Moving Average

$58.59

30.91% above MA-200

MACD Line

-0.56

MACD Signal

-0.85

MACD Histogram

0.29

Bullish

What does CVS's RSI value tell investors?
The RSI (Relative Strength Index) for CVS is currently 49.61, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this shows mixed signals requiring careful analysis.
How should traders interpret CVS's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.56 above the signal line at -0.85, with histogram at 0.29. This bullish crossover suggests upward momentum is building. The 50-day MA ($65.20) is above the 200-day MA ($58.59), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Jun 5, 2025, 12:41 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for CVS and get notified when the price changes.

Stay Ahead of the Market with CVS Health Corporation Alerts

Set up price alerts for CVS Health Corporation and get notified instantly when the price hits your target. Never miss an important price movement again.